Bouwman FH - Search Results

1

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.

Ewers M, Buerger K, Teipel SJ, Scheltens P, Schröder J, Zinkowski RP, Bouwman FH, Schönknecht P, Schoonenboom NS, Andreasen N, Wallin A, DeBernardis JF, Kerkman DJ, Heindl B, Blennow K, Hampel H. Ewers M, et al. Among authors: bouwman fh. Neurology. 2007 Dec 11;69(24):2205-12. doi: 10.1212/01.wnl.0000286944.22262.ff. Neurology. 2007. PMID: 18071141

2

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Galimberti D, et al. Arch Neurol. 2006 Apr;63(4):538-43. doi: 10.1001/archneur.63.4.538. Arch Neurol. 2006. PMID: 16606766

3

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

Bouwman FH, Schoonenboom SN, van der Flier WM, van Elk EJ, Kok A, Barkhof F, Blankenstein MA, Scheltens P. Bouwman FH, et al. Neurobiol Aging. 2007 Jul;28(7):1070-4. doi: 10.1016/j.neurobiolaging.2006.05.006. Epub 2006 Jun 19. Neurobiol Aging. 2007. PMID: 16782233

4

Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders.

Bouwman FH, van der Flier WM, Schoonenboom NS, van Elk EJ, Kok A, Scheltens P, Blankenstein MA. Bouwman FH, et al. Clin Chem. 2006 Aug;52(8):1604-6. doi: 10.1373/clinchem.2006.070193. Clin Chem. 2006. PMID: 16873300 No abstract available.

5

Can lumbar puncture help to identify patients with incipient Alzheimer's disease?

Bouwman FH, van der Flier WM, Scheltens P. Bouwman FH, et al. Nat Clin Pract Neurol. 2006 Oct;2(10):530-1. doi: 10.1038/ncpneuro0295. Nat Clin Pract Neurol. 2006. PMID: 16990823 No abstract available.

6

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

Schoonenboom NS, van der Flier WM, Blankenstein MA, Bouwman FH, Van Kamp GJ, Barkhof F, Scheltens P. Schoonenboom NS, et al. Among authors: bouwman fh. Neurobiol Aging. 2008 May;29(5):669-75. doi: 10.1016/j.neurobiolaging.2006.11.018. Epub 2007 Jan 17. Neurobiol Aging. 2008. PMID: 17208336

7

Longitudinal changes of CSF biomarkers in memory clinic patients.

Bouwman FH, van der Flier WM, Schoonenboom NS, van Elk EJ, Kok A, Rijmen F, Blankenstein MA, Scheltens P. Bouwman FH, et al. Neurology. 2007 Sep 4;69(10):1006-11. doi: 10.1212/01.wnl.0000271375.37131.04. Neurology. 2007. PMID: 17785669

8

CSF biomarker levels in early and late onset Alzheimer's disease.

Bouwman FH, Schoonenboom NS, Verwey NA, van Elk EJ, Kok A, Blankenstein MA, Scheltens P, van der Flier WM. Bouwman FH, et al. Neurobiol Aging. 2009 Dec;30(12):1895-901. doi: 10.1016/j.neurobiolaging.2008.02.007. Epub 2008 Apr 9. Neurobiol Aging. 2009. PMID: 18403055

9

Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements.

Verwey NA, Bouwman FH, van der Flier WM, Veerhuis R, Scheltens P, Blankenstein MA. Verwey NA, et al. Among authors: bouwman fh. Clin Chem Lab Med. 2008;46(9):1300-4. doi: 10.1515/CCLM.2008.241. Clin Chem Lab Med. 2008. PMID: 18601592

10

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.

Sluimer JD, Bouwman FH, Vrenken H, Blankenstein MA, Barkhof F, van der Flier WM, Scheltens P. Sluimer JD, et al. Among authors: bouwman fh. Neurobiol Aging. 2010 May;31(5):758-64. doi: 10.1016/j.neurobiolaging.2008.06.016. Epub 2008 Aug 8. Neurobiol Aging. 2010. PMID: 18692273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page